Biocon announced that its board is scheduled to meet on 4 April 2025 to consider raising funds through issuance of commercial papers (CP) or through any other mode via private placement basis.

Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...

The Board of Directors of Syngene International Limited has approved the appointment of Mr. Peter Bains as an Additional ...

Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/04/2025 ,inter alia, to consider and approve Intimation of Board meeting for raising funds throu ...

Currently, US charges nearly zero duty on pharmaceutical imports, while India imposes around 10 percent tax on pharma imports ...

The Business Research Company Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout. LONDON, GREATER ...

Highlighting the sad state of affairs in the Silicon Valley of India, Biocon chief Kiran Mazumdar-Shaw compared the city’s ...

In early trade on Friday, these stocks dropped by as much as 3%, with the Nifty Auto and Nifty Pharma indices trading lower ...

Step into the world of one of Kannada cinema’s brightest stars, Prabhu Mundkur, a hunk whose captivating presence is simply ...

Track Hindustan Housing Co share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and ...

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

India doesn’t need to build its own from scratch. It can take these models and run with them. The real opportunity isn’t in ...